Outcomes Research May Be “Next Frontier” In Drug Development Science
Executive Summary
Pharmaceutical outcomes research is the "next frontier" for drug development science, FDA Office of Pharmacoepidemiology & Statistical Science Director Paul Seligman, MD, said at a pharmaceutical outcomes research workshop in Tucson, Ariz. Jan. 23
You may also be interested in...
FDA Should Play Role In Rx Cost Control, Ex-HHS Assistant Sec. Slater Says
FDA's mission should be expanded to include a role in controlling the cost of prescription drugs in the U.S., former HHS Assistant Secretary for Health Eve Slater maintains in a Jan. 20 New England Journal of Medicine editorial
FDA Should Play Role In Rx Cost Control, Ex-HHS Assistant Sec. Slater Says
FDA's mission should be expanded to include a role in controlling the cost of prescription drugs in the U.S., former HHS Assistant Secretary for Health Eve Slater maintains in a Jan. 20 New England Journal of Medicine editorial
PhRMA Close To Deal With Tauzin; Changes In Reg Affairs, PR Line Up
The Pharmaceutical Research & Manufacturers of America is understood to be close to finalizing an agreement with Rep. Billy Tauzin (R-La.) to take over as the new CEO of the trade group